Rutgers-RWJMS
New Brunswick, New Jersey, 08850, United States
NCT Number: NCT00820989
The body's immune response to injury or infection is very complex.Endotoxin is a man-made substance, which causes the body to "mimic" sickness (fever,chills, and achiness)for a few hours. This study is designed to determine whether certain proteins, genetics, or heart rate variability change affects the body's response to endotoxin.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Phase 1
New Brunswick, New Jersey, 08850, United States
The body's immune response to injury or infection is very complex.Immune cell activity, the release of specific mediators(such as proteins, genetics(Deoxyribonucleic acid or DNA), the body's "instructions" for making proteins (Ribonucleic Acid or RNA) and heart rate variability (HRV,the intervals between heartbeats) may affect the body's clinical response to stress such as infection.Endotoxin is a man-made substance, which causes the body to "mimic" sickness (fever,chills, and achiness)for a few hours. This study is designed to determine whether any of the above (proteins,genetics,or HRV, etc.) correlate with or affect the body's response to endotoxin.This will enable the investigator to better understand the mechanisms involved in the immune response as well as potential therapeutic strategies to improve outcomes in patients.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Clinical Center Reference Endotoxin, lot 2, sterile saline, 2 ng/kg, bolus IV administration (~5 minutes)
Other names: Sodium Chloride Solution
Time frame: .5-24 hours after Endotoxin administration
Rutgers, The State University of New Jersey
Other
Acronym: Mono
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06513520
Immune System
Caluire-et-Cuire, France
View Trial DetailsNCT05329337
Glucose Metabolism Disorders, Hyperinsulinism
Nîmes, Gard, France
View Trial DetailsNCT06400212
Immune System, Inflammatory Response
York, North Yorkshire, United Kingdom
View Trial DetailsNCT05792137
Immune System, Inflammation
Davis, California, United States
View Trial Details